orforglipron semaglutide comparison New GLP pill, orforglipron, versus established GLP pill, in those with obesity & type 2 diabetes. 1️⃣Average blood sugar improved slightly more with (reduced HbA1c by 2.2% from baseline 8.3%) Very exciting times! , Two
Description
The FDA now notes on semaglutide's label that fracture risk may increase in older adults and women
[DOI] [PMC free article] [PubMed] [Google Scholar] 225.Falkenhain K., Martin C.K., Ravussin E., Redman L.M
Medical and recreational cannabis in the U.S
It is about strength, resilience, and sustainable metabolic function
New products and launches Texas-based Ozzi has launched Crave Crusher, a plant-based drink designed to suppress appetite and serve as an alternative to GLP-1 drugs
